Back to results
US 2004/0204401 A1Published application
Combination therapy for depression, prevention of suicide, and various medical and psychiatric conditions
OwnerPeter Migalyinventor
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
OwnerPeter Migalyinventor
Estimating the term…
The present invention relates to a new method of treatment for persons meeting diagnoses for major depressive disorder, or other unipolar (non-bipolar, non-psychotic and non-treatment resistant) depression. The method comprises administering a combination of two categories of drugs, antipsychotics or dopamine system stabilizers, in combination with a newer antidepressant such as a selective serotonin reuptake inhibitor, as initial treatment or as soon as possible. The method targets the prevention of suicide, and provides other benefits including preventing disease progression development of tolerance toward the antidepressants. Another aspect of the invention relates to using the method for alleviating cognitive distortion and related functional impairment or health risks, and/or using the method for smoking cessation or nicotine withdrawal.
A method for treatment of a patient suffering from major depressive disorder, the method comprising administering to said patient an effective amount of an antidepressant in combination with an antipsychotic drug, said major depressive disorder categorized as non-treatment resistant and non-psychotic.
A method for treatment of a patient suffering from unipolar depression, the method comprising administering to said patient an effective amount of an antidepressant in combination with an antipsychotic drug, said unipolar depression categorized as non-treatment resistant and non-psychotic.
A method for treatment of a patient having cognitive distortions with functional impairment or health hazards or of a patient undergoing smoking cessation or nicotine withdrawal, the method comprising administering to said patient an effective amount of an antidepressant in combination with an antipsychotic drug.
Dependencies are inferred from the claim text.